Nucleo CMP Forte

Indications

• Cerebral edema
• Elevated intracranial pressure
• Acute kidney injury
• Oliguria
• Glaucoma
• Renal function diagnostic aid

Dosage

Adults: For cerebral edema, administer 0

Mechanism of action

Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. This action reduces cerebral edema and intracranial pressure. As a diuretic, it increases the osmolality of glomerular filtrate, leading to increased urinary excretion of water and preventing sodium and chloride reabsorption in the renal tubules. Mannitol also facilitates the urinary excretion of toxic substances and can help in assessing renal function by measuring glomerular filtration rate (GFR).

Pharmacodynamics

Mannitol is classified as an osmotic diuretic. It is chemically similar to other sugar alcohols but has a unique ability to promote diuresis by remaining unabsorbed in the renal tubules. Its use is indicated for conditions associated with increased body fluids, such as cerebral edema and glaucoma. Mannitol may be combined with other diuretics to enhance diuretic efficacy. Inhaled formulations are used in cystic fibrosis, though they may cause bronchospasm and hemoptysis.

Pharmacokinetics

Mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption, which allows for its urinary excretion rate to serve as a measurement of GFR. It does not undergo significant metabolism and is eliminated primarily through the kidneys. The onset of action occurs within 30 to 60 minutes after intravenous administration, with effects lasting for several hours. Administration may require monitoring of renal function and fluid balance.

Contra-indications

• Anuria
• Severe dehydration
• Severe renal impairment
• Intracranial bleeding

Adverse effects

• Asthenia
• Gastrointestinal disturbances
• Dry mouth
• Confusion
• Visual impairment
• Hypotension
• Electrolyte imbalances
• Pulmonary edema
• Hemoptysis (with inhalation use)
• Bronchospasm (with inhalation use)

Interactions

• Potassium-sparing diuretics may increase the risk of hyperkalemia
• Other diuretics may have additive effects
• Caution with nephrotoxic agents

Precautions

• Caution in patients with diabetes mellitus
• Caution in the elderly
• Caution in patients with gout
• Caution in patients with hepatic impairment
• Monitor renal function and electrolytes regularly
• May cause blue fluorescence of urine

Pregnancy

Manufacturer advises avoid due to potential toxicity in animal studies.

Breast-feeding

Manufacturer advises avoid due to lack of information available.

Storage

Store in a cool, dry place, away from light. Do not freeze.

Formulations

• Solution for injection
• Inhalation powder
• Oral solution

Indications

• Acidulant in food and beverages
• Preservative in pharmaceutical formulations
• pH adjuster in various chemical preparations

Dosage

Children: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Adults: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Mechanism of action

Citric acid acts by chelating metal ions, which can enhance the solubility of certain compounds and improve their bioavailability. It also contributes to the acidity of the environment, which can influence enzymatic activity and metabolic pathways, particularly in the degradation of citronellol.

Pharmacodynamics

Citric acid exhibits mild pharmacological effects primarily attributed to its role in metabolic processes. It aids in the regulation of pH levels, which can impact enzymatic reactions and biochemical pathways. The acid's chelating properties may help to reduce the toxicity of certain metal ions in biological systems.

Pharmacokinetics

Citric acid is rapidly absorbed after oral administration and is metabolized in the liver. It undergoes conversion to various metabolites in the citric acid cycle, contributing to energy production. The elimination primarily occurs through urine, with minimal accumulation in the body.

Pregnancy

Citric acid is generally regarded as safe during pregnancy when used in food amounts. However, consult a healthcare provider for advice on medicinal use.

Breast-feeding

Citric acid is considered safe during breastfeeding when consumed in food amounts. For medicinal use, consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Energy supplementation
• Nutritional support
• Weight management
• Athletic performance enhancement

Dosage

Children: Refer to dietary guidelines for recommended daily kcal intake for children based on age, sex, and growth requirements.

Adults: Refer to dietary guidelines for recommended daily kcal intake based on age, sex, activity level, and health status.

Mechanism of action

Kcal itself does not have a direct pharmacological mechanism of action, as it is not a drug but rather a measure of energy. However, the energy derived from kcal influences metabolic pathways, including glycolysis, the citric acid cycle, and oxidative phosphorylation, which are critical for ATP production in cells.

Pharmacodynamics

The pharmacodynamics of kcal are related to how energy intake affects physiological responses in the body. Adequate kcal intake supports basal metabolic rate, thermogenesis, and overall energy balance. Excess kcal can lead to weight gain and associated metabolic disorders, while insufficient kcal can result in malnutrition and energy deficiency, affecting growth, cognitive function, and immune responses.

Pharmacokinetics

Since kcal is not a drug, it does not have pharmacokinetic properties such as absorption, distribution, metabolism, or excretion. The body metabolizes macronutrients (carbohydrates, proteins, and fats) to release energy measured in kcal. The digestion and absorption of these nutrients occur primarily in the gastrointestinal tract, where they are broken down into smaller molecules for utilization by the body.

Pregnancy

Caloric intake is essential during pregnancy for the health of both the mother and the developing fetus. Adequate nutrition should be ensured, but specific caloric needs may vary.

Breast-feeding

Breastfeeding mothers require additional calories to support milk production. It is important to maintain an adequate caloric intake for both maternal health and infant nutrition.

Storage

Store in a cool, dry place, away from direct sunlight. Ensure that food items contributing to caloric intake are properly sealed and stored to prevent spoilage.

Indications

• Cancer (various types)
• Rheumatoid arthritis
• Multiple sclerosis
• Inflammatory bowel disease
• Psoriasis
• Hypercholesterolemia
• Infectious diseases (e.g., COVID-19)

Dosage

Children: Refer to the BNF for Children for paediatric dosing information, as it varies based on the specific monoclonal antibody and the condition being treated.

Adults: Refer to the specific monoclonal antibody product information for adult dosage, as it varies based on indication and specific agent used.

Mechanism of action

Monoclonal antibodies work by binding to specific proteins on the surface of cells. This binding can block the activity of certain proteins, mark cells for destruction by the immune system, or deliver cytotoxic agents directly to target cells. The mechanism of action varies depending on the specific monoclonal antibody but often involves modulation of immune response, inhibition of cell proliferation, and induction of apoptotic pathways.

Pharmacodynamics

The pharmacodynamics of monoclonal antibodies is primarily characterized by their specificity and affinity for targeted antigens. This leads to a variety of effects, including neutralization of pathogens, blockade of receptor-ligand interactions, and antibody-dependent cellular cytotoxicity. The clinical effects depend on the disease being treated and the specific antibody's action, such as inducing tumor regression in cancer or reducing inflammation in autoimmune diseases.

Pharmacokinetics

Monoclonal antibodies typically have a long half-life, allowing for less frequent dosing. They are generally administered intravenously or subcutaneously, with absorption and distribution influenced by the antibody's size and charge. The elimination occurs primarily through proteolytic degradation and intracellular recycling. Factors such as patient-specific variables, including immunogenicity and the presence of antibodies against the monoclonal antibody, can impact pharmacokinetics.

Interactions

• abatacept+monoclonalantibodies: Severe (increases risk of generalised infection (possibly life-threatening))
• anakinra+monoclonalantibodies: Severe (increases risk of generalised infection (possibly life-threatening))
• anthracyclines+monoclonalantibodies: Severe (increases risk of cardiotoxicity)
• filgotinib+monoclonalantibodies: Severe (increases risk of immunosuppression)
• monoclonalantibodies+fingolimod: Severe (increases risk of generalised infection (possibly life-threatening))
• normal immunoglobulin+monoclonalantibodies: Severe (affects effects)
• monoclonalantibodies+ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• monoclonalantibodies+siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• monoclonalantibodies+vemurafenib: Severe (increases risk of hepatotoxicity)
• monoclonalantibodies+aminophylline: Moderate (decreases exposure)

Indications

• Energy metabolism
• Signal transduction
• Nucleotide synthesis
• Regulation of cellular processes

Dosage

Children: Refer to specific clinical guidelines and literature for dosing in paediatric populations, as it varies based on the form and clinical application of the monophosphate.

Adults: Refer to specific clinical guidelines and literature for dosing as it varies based on the form and clinical application of the monophosphate.

Mechanism of action

Monophosphates act primarily by participating in the synthesis and breakdown of nucleic acids and nucleotides. They serve as substrates for various kinases, which catalyze the phosphorylation of molecules, thereby regulating numerous cellular processes including metabolism, cell signaling, and growth. For example, AMP is involved in the regulation of AMP-activated protein kinase (AMPK), which plays a critical role in cellular energy homeostasis.

Pharmacodynamics

Monophosphates influence cellular functions by acting as signaling molecules. They can activate or inhibit various enzymes and pathways, thereby modulating metabolic processes. In the case of AMP, it plays a key role in energy signaling, particularly in response to low energy states, promoting catabolic processes and inhibiting anabolic pathways to restore energy balance.

Pharmacokinetics

Monophosphates are generally water-soluble and are rapidly taken up by cells. They can be phosphorylated to form diphosphates and triphosphates, which are further utilized in various cellular processes. The metabolism of monophosphates is closely linked to cellular energy status and can be influenced by factors such as the availability of substrates and the activity of specific enzymes involved in nucleotide metabolism.

Pregnancy

Consult healthcare provider before use. The effects of monophosphate during pregnancy have not been thoroughly studied.

Breast-feeding

Consult healthcare provider before use. The safety of monophosphate during breastfeeding has not been established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Cellular energy metabolism
• Nucleotide synthesis
• Nucleic acid synthesis
• Signal transduction pathways

Dosage

Children: Refer to specific clinical guidelines as triphosphate is not typically administered as a standalone drug.

Adults: Refer to specific clinical guidelines as triphosphate is not typically administered as a standalone drug.

Mechanism of action

Triphosphate acts as a substrate for nucleotidyl transferases and kinases, facilitating the transfer of phosphate groups in cellular reactions. It is involved in the phosphorylation of proteins and other molecules, contributing to energy metabolism and signal transduction pathways.

Pharmacodynamics

As a high-energy molecule, triphosphate is crucial for ATP synthesis, which is involved in driving numerous cellular processes. It is also part of the signaling pathways due to its role in the synthesis and degradation of nucleotides, influencing cellular functions such as growth, division, and apoptosis.

Pharmacokinetics

Triphosphate is rapidly utilized within cells, with its levels tightly regulated by various enzymes that control its synthesis and degradation. It is not typically administered externally but is produced endogenously from nucleoside triphosphates. Its metabolism is linked to several pathways, including purine nucleotide biosynthesis.

Pregnancy

There is insufficient data on the use of triphosphate during pregnancy to make definitive recommendations.

Breast-feeding

Limited information is available regarding triphosphate excretion in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Electrolyte replacement
• Management of dehydration
• Support in intravenous fluid therapy

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on age and clinical condition.

Adults: Refer to the BNF for specific dosing recommendations based on clinical condition and formulation.

Mechanism of action

Trisodium compounds typically function as electrolytes that help maintain osmotic balance and proper hydration in cells. Sodium ions play a critical role in nerve impulse transmission and muscle contraction, as well as in regulating blood pressure and fluid balance within the body.

Pharmacodynamics

Trisodium compounds affect the body by influencing the electrolyte composition of body fluids. Sodium ions are essential for the depolarization of nerve membranes and the contraction of muscle fibers. They also participate in the regulation of blood volume and blood pressure through their effects on renal function and fluid retention.

Pharmacokinetics

Trisodium compounds are generally absorbed readily from the gastrointestinal tract when ingested. They are distributed throughout the body fluids and tissues, playing a role in maintaining extracellular fluid volume. The kidneys are primarily responsible for the excretion of excess sodium, regulating its concentration in the body to prevent hypernatremia or hyponatremia.

Pregnancy

There is limited data on the safety of trisodium in pregnancy. Caution is advised.

Breast-feeding

Trisodium is not known to be excreted in human milk. Caution is advised.

Storage

Store in a cool, dry place. Protect from light.

Indications

• Cognitive impairment
• Neurodegenerative disorders
• Supportive therapy in conditions of neuronal damage
• Potential use in mitochondrial dysfunction

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Uridine acts as a precursor in the synthesis of nucleotides, particularly in the formation of RNA. It is involved in various biochemical pathways including the pyrimidine ribonucleosides degradation and the superpathways of pyrimidine ribonucleosides salvage. Through its conversion to uridine triphosphate (UTP), it contributes to energy metabolism and cellular signaling processes.

Pharmacodynamics

Uridine exhibits various effects on cellular function, particularly in the central nervous system. It is believed to enhance synaptic transmission and neuroplasticity, potentially benefiting conditions associated with neuronal injury or degeneration. Uridine's role in nucleotide synthesis is vital for RNA production, which is essential for cell proliferation and repair.

Pharmacokinetics

Uridine is absorbed in the gastrointestinal tract and is converted in the liver to various phosphorylated forms. It has a relatively short half-life and is rapidly distributed throughout the body. Metabolism occurs primarily in the liver, and it is excreted in urine. Its pharmacokinetics can be influenced by factors such as age, liver function, and the presence of other medications.

Pregnancy

There is no sufficient data on the use of uridine during pregnancy to determine its safety. Caution is advised.

Breast-feeding

Uridine is excreted in breast milk; therefore, caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat.

Mechanism of action

Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. As a diurectic mannitol induces diuresis because it is not reabsorbed in the renal tubule, thereby increasing the osmolality of the glomerular filtrate, facilitating excretion of water, and inhibiting the renal tubular reabsorption of sodium, chloride, and other solutes. Mannitol promotes the urinary excretion of toxic materials and protects against nephrotoxicity by preventing the concentration of toxic substances in the tubular fluid. As an Antiglaucoma agent mannitol levates blood plasma osmolarity, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure. As a renal function diagnostic aid mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption. Therefore, its urinary excretion rate may serve as a measurement of glomerular filtration rate (GFR). The exact mechanism of action of inhaled mannitol in the symptomatic maintenance treatment of cystic fibrosis remains unclear. It is hypothesized that mannitol produces an osmotic gradient across the airway epithelium that draws fluid into the extracellular space and alters the properties of the airway surface mucus layer, allowing easier mucociliary clearance. MANNITOL IS.../USED/ IN PROPHYLAXIS OF ACUTE RENAL FAILURE. IT IS USED FOR THIS PURPOSE IN CONDITIONS AS DIVERSE AS CARDIOVASCULAR OPERATIONS, SEVERE TRAUMATIC INJURY, OPERATIONS IN THE PRESENCE OF SEVERE JAUNDICE, AND MGMNT OF HEMOLYTIC TRANSFUSION REACTIONS. IN EACH OF THESE CONDITIONS, A PRECIPITOUS FALL IN THE FLOW OF URINE MAY BE ANTICIPATED EITHER AS THE RESULT OF AN ACUTELY REDUCED FILTRATION RATE OR FROM ACUTE CHANGES IN TUBULAR PERMEABILITY. THE LATTER MAY BE CONSEQUENCE OF THE PRESENCE OF NOXIOUS AGENT WITHIN THE TUBULAR FLUID IN EXCESSIVELY HIGH CONCN, IN SOME INSTANCES SUFFICIENT TO RESULT IN ACTUAL PRECIPITATION. IN THESE SITUATIONS, MANNITOL EXERTS OSMOTIC EFFECT WITHIN THE TUBULAR FLUID, INHIBITS WATER REABSORPTION, & MAINTAINS THE RATE OF URINE FLOW. ...CONCN OF TOXIC AGENT WITHIN TUBULAR FLUID DOES NOT REACH EXCESSIVELY HIGH LEVELS THAT OTHERWISE WOULD HAVE BEEN ACHIEVED BY MORE COMPLETE REABSORPTION OF WATER. ...EVEN THOUGH /GLOMERULAR/ FILTRATION RATE IS REDUCED, MANNITOL IS STILL FILTERED @ GLOMERULUS. THE TUBULAR IMPERMEABILITY TO MANNITOL IS NOT ALTERED BY ACUTE RENAL ISCHEMIA OF SHORT DURATION. HENCE, THE MANNITOL THAT IS FILTERED IS ALSO EXCRETED IN THE VOIDED URINE. UNREABSORBED SOLUTE LIMITS BACK DIFFUSION OF WATER. ...URINE VOL CAN BE MAINTAINED EVEN IN PRESENCE OF DECR GLOMERULAR FILTRATION.

Pharmacodynamics

Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement. Inhaled mannitol has the possibility to cause bronchospasm and hemoptysis; the occurrence of either should lead to discontinuation of inhaled mannitol.